Lucinda (Lucy) Tennant is VP, Clinical Operations of Inimmune. Lucy brings over 20 years of clinical operations experience including strategy, planning, and execution of phase 1 – 3 clinical trials. Lucy has extensive experience in operationalizing clinical trials in oncology, specifically for I-O small molecules, cellular and gene therapy, cellular vaccines, and nanoparticle drug conjugates.
After receiving her BSN from the University of Iowa and RN by the state of Iowa, Lucy specialized in oncology nursing with a focus in stem cell transplant and gene therapy research. She then obtained her MS in Healthcare Administration and started her career in the biopharmaceutical industry holding many leadership positions within NewLink Genetics Corporation over 17 years. Lucy has also held leadership positions at Digital Diagnostics and Innovative Cellular Therapeutics.
